Research and specialist diagnostic molecular services

We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.

Research and specialist diagnostic molecular services

We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.

“In situ” hybridization (FISH)

Highly sensitive technique that allows us to detect chromosomal alterations (number of copies of a gene or a chromosomal rearrangements) in different neoplasms for diagnosis and/or targeted treatment, using probes labeled with a fluorochrome.

Molecular Biology

Molecular biology tools allow us to specifically detect and quantify the genetic material in a biological sample, having a great impact on both the diagnosis of cancer and hereditary and infectious diseases. The appearance of new faster and more precise techniques (arrays or NGS), allow us to perform global genomic analyzes in a short period of time.

News

NOVARTIS PIQRAY® RECEIVES POSITIVE CHMP OPINION TO TREAT

Novartis announced the Committee for Medicinal Products for Human Use (CHMP) of the European

FDA APPROVES FIRST THERAPY FOR PATIENTS WITH LUNG

The U.S. Food and Drug Administration (FDA), approved Retevmo (selpercatinib) capsules to treat three

KRAS GENE AMPLIFICATION IN COLORECTAL CANCER AND IMPACT

KRAS mutations are the most common oncogenic event in colorectal cancer (CRC) progression and

FDA APPROVES FIRST NEW DRUG UNDER INTERNATIONAL COLLABORATION,

As part of Project Orbis, the U.S. Food and Drug Administration approved Tukysa (tucatinib) in

VALIDATION AND REFINEMENT OF THE REVISED 2017 EUROPEAN

The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk stratification of acute myeloid

follow us

Do you need any of our services?

Write us